StockData
Novo Nordisk A S logo

Novo Nordisk A S (NVO) income statement

NVONYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NONOF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Score 4/30
$39.43−1.27 (-3.12%)

Close on Nov 18, 2026Market cap $176.06BP/E 11.6Yield –

Novo Nordisk A S income statement

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY2025

Gross margin
81.0%
Operating margin
41.3%
Net margin
–
Return on equity, FY2025
–

Financial strength

Current ratio
0.80
Debt to equity
–
Debt to assets
26.3%
Cash to current liabilities
12.3%

Valuation

P/E ratio
11.6
Price to sales
3.86
Price to book
–
Dividend yield
–

See a number that looks wrong?